TY - JOUR
KW - opioid agonist treatment
KW - amphetamine-type stimulant use
KW - opioid use disorder
KW - Rural Health
KW - Treatment discontinuation
AU - K. A. Morin
AU - F. Vojtesek
AU - S. Acharya
AU - D. C. Marsh
A1 - 
AD - Marsh Research Lab, Northern Ontario School of Medicine, Sudbury, ON, Canada.; ICES North, Sudbury, ON, Canada.; Canadian Addiction Treatment Centre, Markam, ON, Canada.; Marsh Research Lab, Northern Ontario School of Medicine, Sudbury, ON, Canada.; Marsh Research Lab, Northern Ontario School of Medicine, Sudbury, ON, Canada.; Marsh Research Lab, Northern Ontario School of Medicine, Sudbury, ON, Canada.; ICES North, Sudbury, ON, Canada.; Canadian Addiction Treatment Centre, Markam, ON, Canada.; Health Sciences North Research Institute, Sudbury, ON, Canada.
BT - Frontiers in psychiatry
C5 - Education & Workforce; Opioids & Substance Use
DO - 10.3389/fpsyt.2021.782066
JF - Frontiers in psychiatry
LA - eng
M1 - Journal Article
PB - Morin, Vojtesek, Acharya and Marsh
PY - 2021
SN - 1664-0640; 1664-0640; 1664-0640
SP - 782066
T1 - Negative Impact of Amphetamine-Type Stimulant Use on Opioid Agonist Treatment Retention in Ontario, Canada
T2 - Frontiers in psychiatry
TI - Negative Impact of Amphetamine-Type Stimulant Use on Opioid Agonist Treatment Retention in Ontario, Canada
U1 - Education & Workforce; Opioids & Substance Use
U2 - 34987430
U3 - 10.3389/fpsyt.2021.782066
VL - 12
VO - 1664-0640; 1664-0640; 1664-0640
Y1 - 2021
Y2 - Dec 20
ER -